Sulphostin-inspired N-phosphonopiperidones as selective covalent DPP8 and DPP9 inhibitors

被引:0
作者
Sewald, Leonard [1 ]
Tabak, Werner W. A. [1 ]
Fehr, Lorenz [1 ]
Zolg, Samuel [2 ]
Najdzion, Maja [1 ]
Verhoef, Carlo J. A. [1 ,8 ]
Podlesainski, David [1 ,9 ]
Geiss-Friedlander, Ruth [2 ]
Lammens, Alfred [3 ]
Kaschani, Farnusch [1 ]
Hellerschmied, Doris [4 ]
Huber, Robert [5 ,6 ,7 ]
Kaiser, Markus [1 ]
机构
[1] Univ Duisburg Essen, Fac Biol, Ctr Med Biotechnol, Chem Biol, Essen, Germany
[2] Univ Freiburg, Inst Mol Med & Cell Res, Fac Med, Freiburg, Germany
[3] Proteros Biostruct GmbH, Martinsried, Germany
[4] Univ Duisburg Essen, Fac Biol, Ctr Med Biotechnol, Mechanist Cell Biol, Essen, Germany
[5] Univ Duisburg Essen, Fac Biol, Ctr Med Biotechnol, Essen, Germany
[6] Max Planck Inst Biochem, Martinsried, Germany
[7] Tech Univ Munich, TUM Sr Excellence Fac, Munich, Germany
[8] Eindhoven Univ Technol, Inst Complex Mol Syst, Dept Biomed Engn, Lab Chem Biol, Eindhoven, Netherlands
[9] Ruhr Univ Bochum, Fac Biol & Biotechnol, Bochum, Germany
关键词
DIPEPTIDYL-PEPTIDASE-IV; PROTEIN; POTENT; HOMOLOG; MASS; IDENTIFICATION; SPECIFICITY; EXPRESSION; PROBES;
D O I
10.1038/s41467-025-58493-z
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Covalent chemical probes and drugs combine unique pharmacologic properties with the availability of straightforward compound profiling technologies via chemoproteomic platforms. These advantages have fostered the development of suitable electrophilic "warheads" for systematic covalent chemical probe discovery. Despite undisputable advances in the last years, the targeted development of proteome-wide selective covalent probes remains a challenge for dipeptidyl peptidase (DPP) 8 and 9 (DPP8/9), intracellular serine hydrolases of the pharmacologically relevant dipeptidyl peptidase 4 activity/structure homologues (DASH) family. Here, we show the exploration of the natural product Sulphostin, a DPP4 inhibitor, as a starting point for DPP8/9 inhibitor development. The generation of Sulphostin-inspired N-phosphonopiperidones leads to derivatives with improved DPP8/9 inhibitory potency, an enhanced proteome-wide selectivity and confirmed DPP8/9 engagement in cells, thereby representing that structural fine-tuning of the warhead's leaving group may represent a straightforward strategy for achieving target selectivity in exoproteases such as DPPs.
引用
收藏
页数:15
相关论文
共 68 条
  • [1] 3D Structure Generator CORINA Classic, Molecular Networks Altamira
  • [2] Cloning, expression and chromosomal localization of a novel human dipeptidyl peptidase (DPP) IV homolog, DPP8
    Abbott, CA
    Yu, DMT
    Woollatt, E
    Sutherland, GR
    McCaughan, GW
    Gorrell, MD
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (20): : 6140 - 6150
  • [3] Synthesis and biological activity of sulphostin analogues, novel dipeptidyl peptidase IV inhibitors
    Abe, M
    Akiyama, T
    Umezawa, Y
    Yamamoto, K
    Nagai, M
    Yamazaki, H
    Ichikawa, Y
    Muraoka, Y
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (03) : 785 - 797
  • [4] First synthesis and determination of the absolute configuration of sulphostin, a novel inhibitor of dipeptidyl peptidase IV
    Abe, M
    Akiyama, T
    Nakamura, H
    Kojima, F
    Harada, S
    Muraoka, Y
    [J]. JOURNAL OF NATURAL PRODUCTS, 2004, 67 (06): : 999 - 1004
  • [5] Adibekian A, 2011, NAT CHEM BIOL, V7, P469, DOI [10.1038/nchembio.579, 10.1038/NCHEMBIO.579]
  • [6] Crystal structure of human dipeptidyl peptidase IV in complex with a decapeptide reveals details on substrate specificity and tetrahedral intermediate formation
    Aertgeerts, K
    Ye, S
    Tennant, MG
    Kraus, ML
    Rogers, J
    Sang, BC
    Skene, RJ
    Webb, DR
    Prasad, GS
    [J]. PROTEIN SCIENCE, 2004, 13 (02) : 412 - 421
  • [7] DPP-4 Inhibition and the Path to Clinical Proof
    Ahren, Bo
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2019, 10
  • [8] Sulphostin, a potent inhibitor for dipeptidyl peptidase IV from Streptomyces sp MK251-43F3
    Akiyama, T
    Abe, M
    Harada, S
    Kojima, F
    Sawa, R
    Takahashi, Y
    Naganawa, H
    Homma, Y
    Hamada, M
    Yamaguchi, A
    Aoyagi, T
    Muraoka, Y
    Takeuchi, T
    [J]. JOURNAL OF ANTIBIOTICS, 2001, 54 (09) : 744 - 746
  • [9] Natural products in drug discovery: advances and opportunities
    Atanasov, Atanas G.
    Zotchev, Sergey B.
    Dirsch, Verena M.
    Supuran, Claudiu T.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2021, 20 (03) : 200 - 216
  • [10] Rational correction of pathogenic conformational defects in HTRA1
    Beaufort, Nathalie
    Ingendahl, Linda
    Merdanovic, Melisa
    Schmidt, Andree
    Podlesainski, David
    Richter, Tim
    Neumann, Thorben
    Kuszner, Michael
    Vetter, Ingrid R.
    Stege, Patricia
    Burston, Steven G.
    Filipovic, Anto
    Ruiz-Blanco, Yasser B.
    Bravo-Rodriguez, Kenny
    Mieres-Perez, Joel
    Beuck, Christine
    Uebel, Stephan
    Zobawa, Monika
    Schillinger, Jasmin
    Malik, Rainer
    Todorov-Voelgyi, Katalin
    Rey, Juliana
    Roberti, Annabell
    Hagemeier, Birte
    Wefers, Benedikt
    Mueller, Stephan A.
    Wurst, Wolfgang
    Sanchez-Garcia, Elsa
    Zimmermann, Alexander
    Hu, Xiao-Yu
    Clausen, Tim
    Huber, Robert
    Lichtenthaler, Stefan F.
    Schmuck, Carsten
    Giese, Michael
    Kaiser, Markus
    Ehrmann, Michael
    Dichgans, Martin
    [J]. NATURE COMMUNICATIONS, 2024, 15 (01)